Browsing by Keyword : Gastrointestinal Agents
Showing results 1 to 12 of 12
| Pub Year | | Title | AJOU Author(s) |
| 2023 | | Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis | 신성재 |
| 2015 | | Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects. | 김규남, 이광재 |
| 2013 | | Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats. | 이광재 |
| 2016 | | Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study | 신성재 |
| 2018 | | Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial | 이기명 |
| 2015 | | Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. | 이광재 |
| 2024 | | Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease | 김유빈 |
| 2021 | | Multicenter, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of a Controlled-release, Once-daily UIC201609/UIC201610 Combination Therapy for Functional Dyspepsia: Preliminary Study | 이광재 |
| 2012 | | New phytopharmaceutical agent CJ-20001 modulates stress-induced inflammatory infiltration into gastric mucosa | 조성원 |
| 2005 | | Pathophysiology and treatment of functional dyspepsia. | 이광재 |
| 2014 | | Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea. | 정숙희 |
| 2020 | | The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial | 김광민, 김규남, 김범택 |
1
